Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ALEMBIC

  • FDA Approval
  • Oct. 22, 2024, 08:45 UTC
  • 34
  • 0 comments

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

SQ INNOVATION, INC

  • FDA Approval
  • Oct. 21, 2024, 19:12 UTC
  • 42
  • 0 comments

FDA approve FUROSEMIDE

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Oct. 21, 2024, 08:50 UTC
  • 38
  • 0 comments

FDA approve PROPAFENONE HYDROCHLORIDE

Comment Full text

UBI

  • FDA Approval
  • Oct. 21, 2024, 08:50 UTC
  • 36
  • 0 comments

FDA approve LEUPROLIDE ACETATE

Comment Full text

GRANULES

  • FDA Approval
  • Oct. 21, 2024, 08:50 UTC
  • 37
  • 0 comments

FDA approve BUPROPION HYDROCHLORIDE

Comment Full text

AJANTA PHARMA LTD

  • FDA Approval
  • Oct. 21, 2024, 08:50 UTC
  • 36
  • 0 comments

FDA approve FLUVOXAMINE MALEATE

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • Oct. 21, 2024, 08:50 UTC
  • 29
  • 0 comments

FDA approve ATAZANAVIR SULFATE

Comment Full text

BE PHARMS

  • FDA Approval
  • Oct. 21, 2024, 08:50 UTC
  • 31
  • 0 comments

FDA approve FOSAPREPITANT DIMEGLUMINE

Comment Full text

ZENARA PHARMA PRIVATE LTD

  • FDA Approval
  • Oct. 18, 2024, 18:21 UTC
  • 43
  • 0 comments

FDA approve SUGAMMADEX

Comment Full text

ASTELLAS

  • FDA Approval
  • Oct. 18, 2024, 16:50 UTC
  • 41
  • 0 comments

FDA approve ZOLBETUXIMAB-CLZB

Comment Full text
  • Previous
  • 326
  • 327
  • 328
  • 329
  • 330
  • Next

Search

News categories

  • Technical Exchange News(10623)
  • Event(2038)
  • SEC News(185189)
  • FDA Approval(10270)
  • Company Report(721)
  • Business News(122582)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin